Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    Paroxetine in the treatment of recurrent brief depressive disorder

    Sathya Prakash1★, Piyali Mandal1, Rajesh Sagar1★ Corresponding author

    1. 1Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.

    CORRESPONDENCE

    Sathya Prakash

    Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.

    dr.sathyaprakashtbts@gmail.com

    Volume 4, Issue 4 · pp. 288–290 · PUBLISHED 2013 · DOI: 10.4103/0976-500X.119718

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Recurrent brief depressive disorder is now a well‑recognized type of depressive disorder. However, there is still no clear evidence base for its treatment. The efficacy of several drugs including antidepressants and mood stabilizers in this disorder has been controversial. Methodological limitations need to be considered when interpreting the results of studies on efficacy of drugs in this disorder. We report a case of recurrent brief depressive disorder that responded dramatically to paroxetine. However, there is a need for larger, methodologically sound, double‑blind, placebo‑controlled studies.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Prakash, S., Mandal, P., & Sagar, R. (2013). Paroxetine in the treatment of recurrent brief depressive disorder. Journal of Pharmacology and Pharmacotherapeutics, 4(4), 288–290. https://doi.org/10.4103/0976-500X.119718